Agronomics Ltd (ANIC)

Industry Asset Management

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

6.30p

Buy

7.00p

arrow-up0.00p (+0.00%)

Prices updated at 02 Apr 2026, 16:29 BST

Prices minimum 15 mins delay

Prices in GBX

Port Erin Biopharma Investments Ltd invests in biopharmaceutical sector. Its objective is to create value for shareholders through investing in companies that have potential to generate substantial revenues through development of biopharmaceutical drugs.

FTSE All-Share

0.59%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Financial Services

Industry

Asset Management

Chairman

Mr. James Mellon

CEO

-

Most recent earnings

30 Jun 2025

Fiscal year end

30 Jun 2025

Employees

-

Head office

1st Floor, Viking House

Ramsey

Isle of Man

IM8 1GB

+44 1624811454

info@agronomics.im

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Richard John Reed Non-Executive Director	-
Mr. David Anthony Giampaolo Non-Executive Director	-
Mr. Denham Hervey Newall Eke Executive Director, Finance Director	-
Mr. James Mellon Executive Director, Chairman	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Picard Angst AG	4,457,632
Schroder & Co Limited	1,100,000
Thesis Lockerley	1,100,000
Allianz Global Investors GmbH	-
Marlborough International Management Limited	-

Director dealings

Date chevron-l-regular chevron-r-regular	Action
11 Mar 2026	Purchase
03 Mar 2026	Purchase
02 Mar 2026	Purchase
26 Feb 2026	Purchase
19 Feb 2026	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.